ReviewJournal of neurochemistry2019

Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Eugene M Cilento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.